Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Nucleic Acids Research|January 11, 2005
Translation of stable hepadnaviral mRNA cleavage fragments induced by the action of phosphorothioate-modified antisense oligodeoxynucleotidesPeter Hasselblatt, Birgit Hockenjos, Christian Thoma, et al.
Plos One|May 24, 2019
Seasonal variability of vitamin D status in patients with inflammatory bowel disease - A retrospective cohort studyChristine Elisabeth Janssen, Anna Maria Globig, Andrea Busse Grawitz, et al.
Journal of Crohn'S & Colitis|May 4, 2019
Vitamin D Inhibits Pro-Inflammatory T Cell Function in Patients With Inflammatory Bowel DiseaseJosefine Schardey, Anna-Maria Globig, Christine Janssen, et al.
Cancer Research|December 12, 2019
Extracellular ATP and Purinergic P2Y2 Receptor Signaling Promote Liver Tumorigenesis in Mice by Exacerbating DNA DamageIsabel Schulien, Birgit Hockenjos, Veerle van Marck, et al.
Hepatology (Baltimore, Md.)|September 29, 2011
The transcription factor c-Jun protects against sustained hepatic endoplasmic reticulum stress thereby promoting hepatocyte survivalMatthias Fuest, Karolina Willim, Sabine MacNelly, et al.
Cell Death and Differentiation|February 20, 2019
The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expressionIsabel Schulien, Birgit Hockenjos, Annette Schmitt-Graeff, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 24, 2024
Liver cancer development driven by the AP-1/c-Jun~Fra-2 dimer through c-MycLatifa Bakiri, Sebastian C Hasenfuss, Ana Guío-Carrión, et al.
Zeitschrift Fur Gastroenterologie|June 28, 2017
Fatal ulcerative enteritis of the small intestine in a patient with ulcerative colitis treated with vedolizumabCarmen Monasterio, Annette Schmitt-Gräff, Matthias Pohl, et al.
Inflammatory Bowel Diseases|September 24, 2014
Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel diseaseAnna-Maria Globig, Nadine Hennecke, Bianca Martin, et al.
Journal of Clinical Medicine|July 16, 2020
Tofacitinib in Treatment-Refractory Moderate to Severe Ulcerative Colitis: Real-World Experience from a Retrospective Multicenter Observational StudyPeter Hoffmann, Anna-Maria Globig, Anne K Thomann, et al.
Pageof 5